Facebook Linkedin RSS Twitter Youtube
Home 2019

Multiple myeloma

Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies
Cancer

Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies

Liquid Biopsy Technologies Diversify in Expanding CTC Field
Bioprocessing

Liquid Biopsy Technologies Diversify in Expanding CTC Field

Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse Large B-Cell Lymphoma
Cancer

Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse Large B-Cell Lymphoma

Strategies for Preventing Dormant Cancer Cells from Being Reactivated
Cancer

Strategies for Preventing Dormant Cancer Cells from Being Reactivated

AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option
Cancer

AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option

argenx Plans Autoimmune Treatments Using Halozyme’s ENHANZE Drug-Delivery Technology
Drug Discovery

argenx Plans Autoimmune Treatments Using Halozyme’s ENHANZE Drug-Delivery Technology

DNA/RNA Sequencing Offers Hope to Drug-Resistant Multiple Myeloma Patients
Cancer

DNA/RNA Sequencing Offers Hope to Drug-Resistant Multiple Myeloma Patients

Patient Deaths Cited as Darzalex Combination Trials Halted
Cancer

Patient Deaths Cited as Darzalex Combination Trials Halted

MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO
Cancer

MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO

Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
A-Lists

Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017

1...345...15Page 4 of 15
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.